Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 50551-50600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05233787
Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)
NARecruiting
212 participants
Started: Mar 24, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor28 locations
NCT05095649
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
PHASE2Recruiting
15 participants
Started: Mar 24, 2022 · Completed: Feb 15, 2026
1 condition1 sponsor1 location
NCT05477576
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
PHASE3Recruiting
288 participants
Started: Mar 24, 2022 · Completed: Jul 31, 2028
7 conditions1 sponsor53 locations
NCT04162938
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NARecruiting
308 participants
Started: Mar 24, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05285761
feediNg gUidelines infanT RandomIzEd coNtrolled Trial
NARecruiting
330 participants
Started: Mar 24, 2022 · Completed: Mar 31, 2027
1 condition5 sponsors1 location
NCT05307939
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
PHASE2Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2026
5 conditions1 sponsor7 locations
NCT04825990
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
PHASE2Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2028
1 condition1 sponsor1 location
NCT07103694
i-NEED: NEw migrainE Drugs Database
N/ARecruiting
2,641 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05213572
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
N/ARecruiting
200 participants
Started: Mar 24, 2022 · Completed: Jun 1, 2035
5 conditions1 sponsor1 location
NCT06250465
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
N/ARecruiting
500 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor9 locations
NCT05569161
To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty
N/ARecruiting
250 participants
Started: Mar 24, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05323383
The Effects and Mechanisms of Brief Mindfulness Meditation and Hypnosis for Pain
NARecruiting
300 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05287477
Passive Evaluation in Operational Environment of the AI Clinician Decision Support System for Sepsis Treatment
N/ARecruiting
15 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2024
1 condition2 sponsors2 locations
NCT06535451
Lung Cancer Screening Program in Mexico
N/ARecruiting
1,000 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2027
1 condition1 sponsor1 location
NCT05216770
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
EARLY_PHASE1Recruiting
165 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT06144385
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
PHASE1Recruiting
20 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05237245
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
N/ARecruiting
120 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT05184803
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
PHASE2Recruiting
63 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05241418
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
N/ARecruiting
50 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2029
3 conditions1 sponsor1 location
NCT06501469
Biomarkers in Parkinsonian Syndromes
N/ARecruiting
200 participants
Started: Mar 23, 2022 · Completed: Mar 25, 2030
5 conditions2 sponsors1 location
NCT05226117
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
PHASE2Recruiting
44 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04713605
Cerebral Blood Flow in Neonates During Major Cardiac Surgery.
N/ARecruiting
80 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05525338
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
PHASE4Recruiting
196 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2026
5 conditions7 sponsors8 locations
NCT05227664
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
PHASE2Recruiting
120 participants
Started: Mar 23, 2022 · Completed: Dec 30, 2026
2 conditions1 sponsor2 locations
NCT05346757
Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis
NARecruiting
5,390 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05184842
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
PHASE2Recruiting
85 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors3 locations
NCT05430490
Cannabis, HIV and Mental Processing Systems
N/ARecruiting
320 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors2 locations
NCT05329129
"OssDsign® Spine Registry Study (Propel)"
N/ARecruiting
450 participants
Started: Mar 23, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor13 locations
NCT04257526
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program
NARecruiting
500 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2024
1 condition4 sponsors1 location
NCT04021485
BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation
NARecruiting
643 participants
Started: Mar 23, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06254300
Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer
NARecruiting
40 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06342739
Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations
N/ARecruiting
60 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05340361
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
N/ARecruiting
30 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05662722
Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
NARecruiting
60 participants
Started: Mar 22, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05321745
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
NARecruiting
40 participants
Started: Mar 22, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06079827
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
N/ARecruiting
43 participants
Started: Mar 22, 2022 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT04781192
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
PHASE1/PHASE2Recruiting
40 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05376254
3D Assessment of RV Function in Patients Undergoing LVAD Implantation
N/ARecruiting
200 participants
Started: Mar 22, 2022 · Completed: Jan 19, 2027
1 condition1 sponsor1 location
NCT06343272
Lymphocyte Enhancement in Gastroenteric Oncology
NARecruiting
54 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT04831580
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NARecruiting
840 participants
Started: Mar 22, 2022 · Completed: Aug 31, 2029
1 condition2 sponsors136 locations
NCT05277051
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
PHASE1Recruiting
141 participants
Started: Mar 22, 2022 · Completed: Sep 12, 2028
1 condition1 sponsor24 locations
NCT05322876
Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention
NARecruiting
80 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05739253
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
N/ARecruiting
480 participants
Started: Mar 22, 2022 · Completed: Mar 21, 2025
3 conditions1 sponsor1 location
NCT05277025
Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
N/ARecruiting
150 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05223790
Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.
N/ARecruiting
50 participants
Started: Mar 22, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT05433545
Adherence to Physiotherapy Scoliosis Specific Exercises in Adolescents With Spine Deformity: Development of a New Questionnaire
N/ARecruiting
600 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05001880
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
PHASE2Recruiting
66 participants
Started: Mar 22, 2022 · Completed: Aug 20, 2026
1 condition1 sponsor39 locations
NCT05205356
VIGOR: Virtual Genome Center for Infant Health
N/ARecruiting
750 participants
Started: Mar 22, 2022 · Completed: Mar 1, 2027
3 conditions12 sponsors9 locations
NCT05388474
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
N/ARecruiting
200 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2026
2 conditions4 sponsors36 locations
NCT05322343
Biobank and Brain Health in Bordeaux.
N/ARecruiting
2,050 participants
Started: Mar 22, 2022 · Completed: Mar 22, 2030
15 conditions1 sponsor1 location